News

INDONESIA: RECLASSIFICATION OF FILTER PAPER AS A MEDICAL DEVICE – February/March 2025

INDONESIA: RECLASSIFICATION OF FILTER PAPER AS A MEDICAL DEVICE – February/March 2025

  • 2025-02-21 03:51:47

Indonesia's Ministry of Health has reclassified Filter Paper, specifically Dried Blood Spot (DBS) Filter Paper, as a Medical Device. This significant change, effective December 9, 2024, requires manufacturers to register their products as medical devices through the Online Single Submission (OSS) system. This reclassification necessitates compliance with specific regulations and quality standards, impacting product registration and market access in Indonesia.

More
VIETNAM: MINISTRY OF HEALTH EXTENDED THE VALIDITY OF IMPORT LICENSE BY AMENDING AND SUPPLEMENTING DECREE NO. 98/2021/ND-CP, AS REVISED BY DECREE NO. 07/2023/ND-CP – February/March 2025

VIETNAM: MINISTRY OF HEALTH EXTENDED THE VALIDITY OF IMPORT LICENSE BY AMENDING AND SUPPLEMENTING DECREE NO. 98/2021/ND-CP, AS REVISED BY DECREE NO. 07/2023/ND-CP – February/March 2025

  • 2025-02-20 10:09:30

Decree No. 04/2025/NĐ-CP, released on January 1st, 2025, by Vietnam MOH, extending the validity of import license until June 30, 2025, on the Decree amending and supplementing of Clause 2, Clause 3, and Clause 4, Article 76 of Decree No. 98/2021/ND-CP, as revised by Decree No. 07/2023/ND-CP, regarding medical device management.

More
Qualtech's Silver Jubilee: Highlights of 2024 and the Vision for 2025 – January/February 2025

Qualtech's Silver Jubilee: Highlights of 2024 and the Vision for 2025 – January/February 2025

  • 2025-01-22 09:19:30

In 2024, Qualtech Consulting Corporation achieved significant milestones, including expanding our services to support Korean MFDS registrations, celebrating the 10th anniversary of our Malaysian office, and hosting impactful webinars addressing regulatory and market opportunities in Europe, ASEAN, Brazil, and India. As we prepare for 2025, we are focused on expanding knowledge-sharing efforts, entering emerging markets such as Latin America and the Middle East, and celebrating 25 years of supporting medical device manufacturers globally.

More
Greying Korea: Can MedTech Devices Beat the Chronic Disease Wave? – January/February 2025

Greying Korea: Can MedTech Devices Beat the Chronic Disease Wave? – January/February 2025

  • 2025-01-22 07:51:43

South Korea's rapidly aging population is driving a surge in chronic diseases, creating a lucrative market for medical devices. This article will highlight the growing demand for diagnostic tools, remote patient monitoring devices, wearable health trackers, cardiovascular and orthopedic devices, and diabetes care devices. With significant market projections, South Korea offers promising opportunities for foreign medical device manufacturers.

More
Australia: Understanding the Therapeutic Goods Administration's (TGA) Recall Reforms and the Introduction of the PRAC – January/February 2025

Australia: Understanding the Therapeutic Goods Administration's (TGA) Recall Reforms and the Introduction of the PRAC – January/February 2025

  • 2025-01-22 07:36:15

The Therapeutic Goods Administration (TGA) has introduced the Procedure for Recalls, Product Alerts, and Product Corrections (PRAC) to streamline and enhance the recall processes for therapeutic goods in Australia. By reducing recall categories, simplifying procedural steps, and improving communication, the PRAC aims to foster efficiency and clarity for manufacturers and regulatory consultants. With implementation set for March 2025, stakeholders are encouraged to prepare for these reforms to ensure compliance and contribute to a safer therapeutic goods landscape.

More
QT Promotion: Streamlining Medical Device Registration and Compliance in China with Qualtech – December/January 2025

QT Promotion: Streamlining Medical Device Registration and Compliance in China with Qualtech – December/January 2025

  • 2024-12-16 10:35:14

Qualtech simplifies medical device registration and post-market compliance in China by addressing NMPA requirements with personalized guidance and localized expertise. From ensuring submission-ready dossiers to managing regulatory feedback and proactive surveillance, their support streamlines compliance, safeguards product reliability, and enhances market success.

More